The NLRP3 inflammasome may also inhibit CRC metastasis and proliferation by enhancing the IL-18-induced activity of NK cells independently of INF-γ, in addition to counteracting enterocolitis-associated intestinal carcinogenesis. Here, IL18 is linked to colorectal carcinoma.